Skip to main content

Nanophase Technologies Value Stock - Dividend - Research Selection

Nanophase technologies

ISIN: US6300791018 , WKN: 910885

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Nanophase Technologies Corporation develops and manufactures advanced materials and applications with an integrated nanomaterial and related technologies. It produces engineered nano and larger, and sub-micron materials for use in various markets, which comprise personal care, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy, and various surface finishing technologies. The company was founded in 1989 and is headquartered in Romeoville, Illinois.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Zomedica And 3 Other Stocks Under $3 Insiders Are Buying

2024-05-14
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Nanophase Technologies Corporation (PNK:NANX) Q1 2024 Earnings Call Transcript

2024-04-25
Nanophase Technologies Corporation (PNK:NANX) Q1 2024 Earnings Call Transcript April 24, 2024 Nanophase Technologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to today’s program entitled Nanophase’s First Quarter 2024 Financial Conference […]

Nanophase Technologies Corp (NANX) Q1 2024 Earnings Call Transcript Highlights: A Turnaround ...

2024-04-25
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Nanophase Technologies Corporation (NANX) Q1 2024 Earnings Call Transcript

2024-04-24
Nanophase Technologies Corporation (OTC:NANX) Q1 2024 Results Conference Call April 24, 2024 11:00 AM ETCompany ParticipantsJess Jankowski - President and...

Nanophase Reports Record First Quarter Results

2024-04-23
— Delivered $9.9 Million in Q1 Revenue— $0.9 Million in Profit— BASF Litigation Resolved ROMEOVILLE, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the first quarter ended March 31, 2024. Jess Jankowski

NANX Stock Earnings: Nanophase Technologies Reported Results for Q1 2024

2024-04-23
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Nanophase Technologies GAAP EPS of $0.01, revenue of $9.9M

2024-04-23
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Nanophase Technologies Announces First Quarter 2024 Financial Release and Conference Call Details

2024-04-19
Romeoville, Ill., April 19, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the First Quarter 2024 after market close on Tuesday, April 23, 2024, with an investor conference call to f

Nanophase Announces Successful Litigation Settlement

2024-04-11
ROMEOVILLE, Ill., April 11, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — announced today that it has agreed to a successful and amicable resolution of all ongoing litigation with BASF. The parties have executed a Settlement Agreement, an amendment to the

Nanophase to settle litigation with BASF

2024-04-11
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.